Pearls & Pitfalls In patients with chronic tubulointerstitial nephritis, angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) should not be used together because of the additive risk of hyperkalemia and acceleration of disease progression.